INS and sarcopenia: Studies suggest that multiple cellular, hormonal, metabolic, and molecular mechanisms underlie the development of sarcopenia in animal models, including impaired insulin signaling, imbalanced anabolic and catabolic energy metabolism, upregulation of catabolic cytokine expression, immune dysfunction, systemic inflammation, and increased oxidative stress (A Sayer, Stewart, Patel, & Cooper, 2010).